Martha H. Marsh - 12 May 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: Director
Issuer ticker: EW
Reported as of: 12 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 May 2023, 18:23:38 UTC
Prior SEC filing: 25 Apr 2023
Next SEC filing: 19 May 2023
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Filing notes and source

Key filing fact

Martha H. Marsh filed Form 4 for Edwards Lifesciences Corp (EW) on 15 May 2023.

Key facts

This page summarizes Martha H. Marsh's Form 4 filing for Edwards Lifesciences Corp (EW).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 May 2023, 18:23.

Change

Previous filing in this sequence was filed on 25 Apr 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Award

Transaction value: $0
Shares: +2,803
Change %: +9.6%
Price: $0.000000
Shares after: 31,880
Date: 12 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These restricted stock units were granted on May 12, 2023 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.